Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Apr 2012

Garrett Nigel J, Apea Vanessa, Nori Achyuta, Ushiro-Lumb Ines, Oliver Anthony R, Baily Guy, Clark Duncan A

Abstract excerpt

BACKGROUND: The Roche COBAS TaqMan HIV-1 version 1.0 (v1.0) real-time PCR test detects more low level viral loads (VL) compared to the previous Roche Amplicor version 1.5 assay. Due to under-quantification issues, the Roche TaqMan HIV-1 version 2.0 (v2.0) was introduced in 2009. Controversy remai...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to HIV-1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Reagent Kits, Diagnostic

Share to Real-Time Polymerase Chain Reaction

Share to Reproducibility of Results

Share to RNA, Viral

Share to Viral Load

Source

Identifiers

PMID: 22261125
DOI: 10.1016/j.jcv.2011.12.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22261125-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of the rate and size of HIV-1 viral load blips with Roche COBAS TaqMan HIV-1 versions 1.0 and 2.0 and implications for patient management.PMID 22261125Read ↗

Increased Frequency of HIV-1 Viral Load Blip Rate Observed After Switching From Roche Cobas Amplicor to Cobas Taqman AssaySemantic proximity Read ↗

Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.Semantic proximity Read ↗

Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia.Semantic proximity Read ↗

Comparative Performances of HIV-1 RNA Load Assays at Low Viral Load Levels: Results of an International CollaborationSemantic proximity Read ↗

Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays - implications for response-guided therapy in genotype 1 infections.Semantic proximity Read ↗

How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis.Semantic proximity Read ↗

The HIV Virologic Outcomes of Different Interventions Among Treatment-Experienced Patients With 2 Consecutive Detectable Low-Level Viremia.Semantic proximity Read ↗

HIV: how to manage low-level viraemia in people living with HIVSemantic proximity Read ↗

Truegene HIV-1 genotyping kit approval.Semantic proximity Read ↗

Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.Semantic proximity Read ↗

Comparison of four commercial viral load techniques in an area of non-B HIV-1 subtypes circulation.Semantic proximity Read ↗

Single-Point Mutations Causing More than 100-Fold Underestimation of Human Immunodeficiency Virus Type 1 (HIV-1) Load with the Cobas TaqMan HIV-1 Real-Time PCR AssaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.